SBFM vs. KO
SBFM (Sunshine Biopharma Inc) and KO (The Coca-Cola Company) are both stocks. SBFM operates in Drug Manufacturers - Specialty & Generic (Healthcare), while KO operates in Beverages - Non-Alcoholic (Consumer Defensive). Over the past 10 years, SBFM returned -54.62%/yr vs 10.64%/yr for KO. Their -0.01 correlation means they have often moved in opposite directions in the past.
Performance
SBFM vs. KO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBFM achieves a -90.49% return, which is significantly lower than KO's 26.97% return. Over the past 10 years, SBFM has underperformed KO with an annualized return of -54.62%, while KO has yielded a comparatively higher 10.64% annualized return.
SBFM
- 1D
- -4.88%
- 1M
- -44.55%
- 6M
- -90.41%
- YTD
- -90.49%
- 1Y
- -91.70%
- 3Y*
- -95.11%
- 5Y*
- -77.90%
- 10Y*
- -54.62%
- ALL TIME*
- -53.29%
KO
- 1D
- -1.02%
- 1M
- 4.10%
- 6M
- 18.65%
- YTD
- 26.97%
- 1Y
- 30.80%
- 3Y*
- 15.70%
- 5Y*
- 12.23%
- 10Y*
- 10.64%
- ALL TIME*
- 12.27%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.49B | $1.47B | $1.44B | |
| $241.19K | $163.56K | $7.44M |
SBFM vs. KO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBFM Sunshine Biopharma Inc | -90.49% | -59.00% | -99.45% | -57.58% | 994.95% | 272.29% | 3,388.89% | -97.19% | -93.28% | 197.50% |
KO The Coca-Cola Company | 26.97% | 15.60% | 8.88% | -4.43% | 10.61% | 11.37% | 2.47% | 20.60% | 6.77% | 14.38% |
Correlation
The correlation between SBFM and KO is -0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.03 |
Correlation (3Y) Balances recent behavior with more history. | -0.04 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.01 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.02 |
Correlation (All Time) Calculated using the full available price history since Oct 30, 2009 | -0.01 |
Fundamentals
SBFM:
$585.69K
KO:
$376.85B
SBFM:
-$1.36
KO:
$3.32
SBFM:
0.14
KO:
7.54
SBFM:
0.21
KO:
10.45
SBFM:
$36.31M
KO:
$50.13B
SBFM:
$12.26M
KO:
$31.02B
SBFM:
-$5.62M
KO:
$19.57B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBFM vs. KO — Risk / Return Rank
SBFM
KO
SBFM vs. KO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sunshine Biopharma Inc (SBFM) and The Coca-Cola Company (KO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBFM | KO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.47 | ||
| Sortino ratioReturn per unit of downside risk | -4.77 | ||
| Omega ratioGain probability vs. loss probability | 0.70 | 1.32 | -0.62 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 4.17 | -5.14 |
| Martin ratioReturn relative to average drawdown | -1.74 | 9.09 | -10.84 |
Loading charts...
Drawdowns
SBFM vs. KO - Drawdown Comparison
The maximum SBFM drawdown since its inception was -100.00%, which is greater than KO's maximum drawdown of -68.23%. Use the drawdown chart below to compare losses from any high point for SBFM and KO.
Loading charts...
Drawdown Indicators
| SBFM | KO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -68.23% | -31.77% |
Max Drawdown (1Y)Largest decline over 1 year | -94.68% | -7.87% | -86.81% |
Max Drawdown (3Y)Largest decline over 3 years | -99.99% | -15.50% | -84.49% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -17.27% | -82.73% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -36.99% | -63.01% |
Current DrawdownCurrent decline from peak | -100.00% | -1.67% | -98.33% |
Average DrawdownAverage peak-to-trough decline | -88.91% | -16.06% | -72.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.64% | 3.60% | +49.04% |
Volatility
SBFM vs. KO - Volatility Comparison
Sunshine Biopharma Inc (SBFM) has a higher volatility of 19.68% compared to The Coca-Cola Company (KO) at 9.09%. This indicates that SBFM's price experiences larger fluctuations and is considered to be riskier than KO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBFM | KO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.68% | 9.09% | +10.59% |
Volatility (6M)Calculated over the trailing 6-month period | 118.41% | 15.06% | +103.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 129.48% | 18.66% | +110.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6,608.57% | 16.64% | +6,591.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 4,761.95% | 18.42% | +4,743.53% |
Dividends
SBFM vs. KO - Dividend Comparison
SBFM has not paid dividends to shareholders, while KO's dividend yield for the trailing twelve months is around 2.37%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KO The Coca-Cola Company | 2.37% | 2.92% | 3.12% | 3.12% | 2.77% | 2.84% | 2.99% | 2.89% | 3.29% | 3.23% | 3.38% | 3.07% |
SBFM Sunshine Biopharma Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SBFM vs. KO - Financials Comparison
This section allows you to compare key financial metrics between Sunshine Biopharma Inc and The Coca-Cola Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SBFM vs. KO - Profitability Comparison
SBFM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Sunshine Biopharma Inc reported a gross profit of 3.03M and revenue of 8.58M. Therefore, the gross margin over that period was 35.3%.
KO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Coca-Cola Company reported a gross profit of 8.42B and revenue of 13.38B. Therefore, the gross margin over that period was 62.9%.
SBFM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Sunshine Biopharma Inc reported an operating income of -1.79M and revenue of 8.58M, resulting in an operating margin of -20.9%.
KO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Coca-Cola Company reported an operating income of 4.67B and revenue of 13.38B, resulting in an operating margin of 34.9%.
SBFM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Sunshine Biopharma Inc reported a net income of -2.14M and revenue of 8.58M, resulting in a net margin of -25.0%.
KO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Coca-Cola Company reported a net income of 4.43B and revenue of 13.38B, resulting in a net margin of 33.1%.
Frequently Asked Questions
SBFM and KO have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBFM has higher volatility (19.68%) compared to KO (9.09%). In terms of maximum drawdown, SBFM dropped -100.00% vs KO's -68.23%.
KO currently has the higher Sharpe Ratio (1.76 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBFM and KO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer